New Blood-Cleansing therapy tested for Hard-to-Treat nerve disorder
NCT ID NCT07154524
Summary
This study is testing a blood-filtering treatment called immunoadsorption for people with chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune nerve disease. It will involve about 140 patients in Germany who haven't responded well to standard treatments like intravenous immunoglobulins or steroids. The goal is to see if switching to this blood-cleansing procedure is safe and helps control the disease better over an 18-month observation period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Ulm
RECRUITINGUlm, Baden-Wurttemberg, 89081, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.